Po Hsiang Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Po Hsiang Zhang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Cheng-Yung Lin
Institute of Biomedical Sciences, Mackay Medical College, New Taipei City 25245, Taiwan
1 shared publication Chia Lun Wu
Institute of Molecular and Cellular Biology, National Taiwan University, Taipei, Taiwan
1 shared publicationChia Yu Chang
Bioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien City, Taiwan
1 shared publicationHorng Jyh Harn
Bioinnovation Center, Buddhist Tzu Chi Medical Foundation, Hualien City, Taiwan
1 shared publication- Huai-Jen Tsai
Department of Life Science, Fu Jen Catholic University, New Taipei City, Taiwan
1 shared publication - Kok Zhi Lee
Department of Energy, Environmental & Chemical Engineering Washington University in St. Louis Saint Louis Missouri USA
1 shared publication
Latest Publications
- Open Access
- 30 July 2019
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 8
Extracellular Pgk1 enhances neurite outgrowth of motoneurons through Nogo66/NgR-independent targeting of NogoA
NogoA inhibits neurite outgrowth of motoneurons (NOM) through interaction with its receptors, Nogo66/NgR. Inhibition of Nogo receptors rescues NOM, but not to the extent exhibited by NogoA-knockout mice, suggesting the presence of other pathways. We found that NogoA-overexpressing muscle cells reduced phosphoglycerate kinase 1 (Pgk1) secretion, resulting in inhibiting NOM. Apart from its glycolytic role and independent of the Nogo66 pathway, extracellular Pgk1 stimulated NOM by triggering a reduction of p-Cofilin-S3, a growth cone collapse marker, through decreasing a novel Rac1-GTP/p-Pak1-T423/p-P38-T180/p-MK2-T334/p-Limk1-S323/p-Cofilin-S3 molecular pathway. Not only did supplementary Pgk1 enhance NOM in defective cells, but injection of Pgk1 rescued denervation in muscle-specific NogoA-overexpression of zebrafish and an Amyotrophic Lateral Sclerosis mouse model, SOD1 G93A. Thus, Pgk1 secreted from muscle is detrimental to motoneuron neurite outgrowth and maintenance.
- 30 July 2019
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 8
Open AccessExtracellular Pgk1 enhances neurite outgrowth of motoneurons through Nogo66/NgR-independent targeting of NogoA
NogoA inhibits neurite outgrowth of motoneurons (NOM) through interaction with its receptors, Nogo66/NgR. Inhibition of Nogo receptors rescues NOM, but not to the extent exhibited by NogoA-knockout mice, suggesting the presence of other pathways. We found that NogoA-overexpressing muscle cells reduced phosphoglycerate kinase 1 (Pgk1) secretion, resulting in inhibiting NOM. Apart from its glycolytic role and independent of the Nogo66 pathway, extracellular Pgk1 stimulated NOM by triggering a reduction of p-Cofilin-S3, a growth cone collapse marker, through decreasing a novel Rac1-GTP/p-Pak1-T423/p-P38-T180/p-MK2-T334/p-Limk1-S323/p-Cofilin-S3 molecular pathway. Not only did supplementary Pgk1 enhance NOM in defective cells, but injection of Pgk1 rescued denervation in muscle-specific NogoA-overexpression of zebrafish and an Amyotrophic Lateral Sclerosis mouse model, SOD1 G93A. Thus, Pgk1 secreted from muscle is detrimental to motoneuron neurite outgrowth and maintenance.